Introduction
Niemann Pick Type-C (NPC) disease is an autosomal recessive disorder that is characterized by liver disease, lung disease and neurodegeneration that lead to premature death (reviewed in [1] ). Mutations in either NPC1 or NPC2 lead to the accumulation of lipids, particularly cholesterol that is derived from endocytosed lipoproteins [2] , within late endosomes/lysosomes (LE/L) of all cells [3] including neurons [4] and astrocytes [5] . The two NPC proteins, NPC1 and NPC2, act in tandem in the LE/L to mediate the egress of cholesterol from the LE/L [6] .
Neuronal death occurs progressively in NPC disease, with Purkinje neurons of the cerebellum being particularly affected [7, 8] . However, the mechanism underlying the neurodegeneration remains unclear.
Apoptotic neurons have been detected by TUNEL staining in the cerebral cortex and cerebellum of NPC patients and NPC1-deficient mice [9] . In addition, in the Npc1 −/− mouse cerebellum, levels of mRNAs encoding apoptotic markers such as caspase-1 and -3 are elevated [8] , and the c-Abl/p73 apoptotic pathway is activated [10] . Furthermore, amounts of mRNAs encoding the pro-inflammatory cytokine tumor necrosis factor-α (TNFα) and other components of the TNF death pathway are increased in the cerebellum of NPC1-null mice [8, 9, 11] . The events underlying the increased apoptosis of neurons in response to NPC deficiency have not been elucidated in detail but might include leakage of lysosomal enzymes and oxidative stress [12] . In addition, dysfunction of non-neuronal cells in the brain, such as microglia and/or astrocytes, has been proposed to contribute to the neurodegeneration that characterizes NPC disease [13, 14] . Microglia are resident immune cells of the central nervous system (CNS) and play a crucial role in maintaining health and function of the brain. In a healthy brain, the microglia constantly monitor their surroundings with their ramified processes [15] . When the microglia detect disturbances to the brain environment, such as cell damage or an invading pathogen, the microglia can become activated. Depending upon the activating stimulus, the microglia invoke various responses that include migration to the site of injury [16, 17] , proliferation [18] and phagocytosis of dying cells and debris [19] . Additionally, microglia can generate an inflammatory response through the release of proinflammatory cytokines [20, 21] , glutamate [22] , reactive oxygen species [23] , and nitric oxide [24] . Although inflammation is a mechanism for protection of the CNS, molecules produced during an inflammatory response are potentially cytotoxic so that the microglia must tightly control the extent of inflammation. Consequently, the microglia also produce anti-inflammatory cytokines and neuroprotective molecules such as growth factors [25] [26] [27] that allow the microglia to shift from a classical pro-inflammatory state to a more neuroprotective state so that repair and regeneration of damaged tissue can occur [28] . These wideranging capabilities provide the microglia with the first line of defense against a variety of insults to the CNS. Increasing evidence suggests that chronic activation and/or dysfunction of microglia can contribute to neuron death in neurodegenerative disorders such as Alzheimer disease and Parkinson disease (reviewed in [29] ). Moreover, replacement of mutant microglia with wild-type microglia by bone marrow transplantation in mouse models of amyotrophic lateral sclerosis and Sandhoff disease (a lysosomal storage disorder) delayed the onset, and slowed the course, of these diseases [30, 31] . On the other hand, microglial defects are not the primary determinants of CNS pathology in Gaucher's disease, another lysosomal lipid storage disease [32] . In the brains of NPC1-deficient mice the number of microglia is markedly increased and these microglia exhibit an activated morphology [13, 33, 34] . Microglia proliferate in specific regions of the NPC1-deficient brain, such as the thalamus and cerebellum, and the activated microglia eventually spread throughout the brain as the disease progresses [13] . Interestingly, this activation/proliferation of microglia was observed prior to any detectable neurodegeneration [13] , suggesting that microglia might play a role in initiating the neurodegeneration in NPC disease. Nevertheless, neuronal damage that was undetectable by the techniques employed might have contributed to activation of the microglia. It is also possible that cholesterol sequestration in NPC1-deficient microglia alters microglial function and renders these cells less able to perform normal neuroprotective functions.
Thus, the role of microglia in NPC disease is controversial. A key question is: do activated NPC1-deficient microglia initiate and/or exacerbate neuronal death, or do microglia become activated in response to cell death in an attempt to prevent further neuronal death? We, therefore, investigated the role of microglia in NPC disease using primary microglia isolated from Npc1 −/− and Npc1 +/+ mice.
Experiments were performed with co-cultures of primary microglia and primary neurons to test the hypothesis that NPC1 deficiency in microglia causes neuron death.
Materials and methods

Materials
Dulbecco's Modified Eagle Medium (DMEM) high glucose, Ham's F12 medium, Neurobasal medium, fetal bovine serum (FBS), B27 supplement and 0.25% trypsin-EDTA were purchased from Invitrogen. L-glutamine, poly-D-lysine hydrobromide and trypsin (type XII-S from bovine pancreas) were purchased from Sigma, deoxyribonuclease I (DNAse I) was from Worthington Biochemical Corporation (Lakewood, NJ) and U18666A was from Biomol Research Laboratories (Plymouth Meeting, PA (Sigma), as described [35] . All experiments were approved by the Health Sciences Animal Welfare Committee of the University of Alberta.
Immunohistochemical staining of mouse brain slices
Samples from brains of 7-week-old Npc1 +/+ and Npc1 −/− mice were prepared according to Amritraj et al. [12] . Briefly, mice were anesthetized with 4% chloral hydrate, then perfused with phosphatebuffered saline (PBS) and subsequently with 4% (w/v) paraformaldehyde. Brains were sectioned (20 μM) on a cryostat and processed using the free-floating procedure [36, 37] . 
Isolation and culture of cortical glia
Glial cells were isolated from cerebral cortices of 1-to 3-day-old Npc1 +/+ and Npc1 −/− mice [38] . The cortices were cleaned of meninges and blood vessels, finely chopped, and digested in 0.25% trypsin (Invitrogen) containing 1 mg/mL DNAse I (Worthington). Cells were dissociated by trituration through a Pasteur pipette in DMEM containing 10% FBS. Glial cells were pelleted by centrifugation at 950 rpm, re-suspended in fresh DMEM containing 10% FBS, then plated at a density of two cortices/75-cm 2 flask or one cortex/25-cm 2 flask. Cultures were maintained at 37°C and 5% CO 2 in DMEM containing 10% FBS. Medium was replaced every 3-5 days.
Isolation and culture of cortical microglia
Microglia were isolated using the mild trypsinization method [39] . Confluent cultures of mixed glial cells were maintained in flasks for 3 to 4 weeks, then washed with DMEM:Ham's F12 medium (1:1) and incubated at 37°C with DMEM:Ham's F12 medium (1:1) containing 0.0625% trypsin for 30-60 min until the astrocyte layer lifted. Medium and the astrocyte layer were aspirated leaving microglia attached to the dish. For qPCR analysis, microglia were washed once with DMEM: Ham's F12 medium (1:1) containing 10% FBS, followed by a wash with DMEM:Ham's F12 medium (1:1). Microglia were incubated in the latter medium at 37°C and 5% CO 2 for 24 h. In some experiments, after removal of the astrocyte layer, microglia were incubated with 0.25% trypsin at room temperature and subsequently scraped from the dish. DMEM:Ham's F12 medium (1:1) containing 10% FBS was added to the cell suspension, cells were pelleted at 950 rpm and microglia were resuspended in fresh DMEM:Ham's F12 medium (1:1) containing 10% FBS. Microglia were plated in 96-well plates at a density of 62,500 cells/well. According to immunocytochemical staining for the microglial marker Iba1 and the astrocyte marker, glial fibrillary acidic protein, as well as labeling of nuclei by Hoechst staining, the cultures contained N90% microglia, consistent with~98% microglia reported previously with this method [39] .
Isolation and culture of neurons
Cerebellar granule cells (CGCs) were cultured as described [40] with minor modifications. Briefly, cerebella were dissected from 7-to 8-day-old mice, cleaned of meninges and blood vessels, finely chopped, and digested in 0.25% trypsin containing 1 mg/mL DNAse I. Cells were dissociated by trituration through a fire-polished Pasteur pipette in Neurobasal medium containing 10% heat-inactivated FBS. Dissociated cells were pelleted by centrifugation at 950 rpm, resuspended in Neurobasal medium supplemented with 2% B27, 0.5 mM glutamine and 20 mM potassium chloride, then passed through a 40 μm nylon cell strainer (BD Biosciences, Bedford, MA) to remove clumped cells. Trypan blue-excluding cells were counted using a hemocytometer and plated at a density of 31,250 cells/well in 96-well plates coated with 10 μg/mL poly-D-lysine hydrobromide. Cells were maintained at 37°C and 5% CO 2 without re-feeding for 7 days until used for experiments.
Cortical neurons were isolated from the cortex of one-day-old mice by the same protocol that was used for CGCs [40] . The neurons were maintained in Neurobasal A medium (Invitrogen) supplemented with 2% B27 and 0.5 mM glutamine at 37°C and 5% CO 2 without re-feeding for 3-4 days until used for experiments.
Filipin staining
Npc1
+/+ and Npc1 −/− microglia were isolated as described earlier, plated in 96-well plates and allowed to rest overnight. The microglia were washed with PBS, fixed for 15 min in 4% (w/v) paraformaldehyde and stained for 1.5 h with filipin (0.15 mg/mL) at room temperature. The cells were then washed with PBS and examined with a Leica DM IRE2 fluorescence microscope (Leica Microsystems, Bannockburn, IL) at an excitation wavelength of 351 nm. Images were captured using Open Lab 3.1.4 Software (PerkinElmer, Waltham, MA) and processed using Adobe Photoshop CS4 (San Jose, CA).
Measurement of TNFα secretion
Npc1 +/+ and Npc1 −/− microglia were isolated as described earlier, plated in 96-well plates, and allowed to rest overnight. Medium was removed and the cells were incubated for 24 h with fresh DMEM/Ham's F12 medium (1:1) containing 10% FBS. Media were collected and stored at −20°C. Amounts of TNFα secreted into the culture medium were determined by ELISA with a standard curve (Biosource, Camarillo, CA), according to manufacturer's instructions.
RNA isolation and quantitative real-time PCR analysis
Npc1 +/+ and Npc1 −/− microglia were cultured in 75-cm 2 flasks for 24 h in DMEM:Ham's F12 medium (1:1) then washed with ice-cold PBS. Total RNA was isolated using the RNeasy Mini Kit (Invitrogen) and stored at −80°C. RNA was treated with DNAse I (amplification grade) to prevent DNA contamination and cDNA was synthesized from 0.5 μg total RNA using oligo(dT) 12-18 random primers and Superscript II reverse transcriptase according to manufacturer's instructions. qPCR reactions were performed using Platinum® Quantitation PCR supermix, SYBR Green I and 250 nmol of gene-specific primers in a total volume of 25 μL in 0.2 mL tubes (Axygen, Union City, CA). Transcripts were detected by qPCR with a Rotor-Gene 3000 instrument (Montreal Biotech, Montreal, QC) and data were analyzed with Rotor-Gene 6.0.19 software. Amounts of transcripts were determined using the standard curve method. Intronspanning primers were designed using OLIGO 6.71 software (Cascade, CO) and specificity was confirmed with the NCBI BLAST nucleotide query tool, by melt curve analysis, and by agarose gel electrophoresis. All primers were synthesized by IDT Technologies (San Diego, CA) (sequences shown in Table 1 ). Data were normalized to levels of control mRNA encoding glyceraldehyde-3-phosphate dehydrogenase. 
Phagocytosis assay
Npc1 +/+ and Npc1 −/− microglia were plated in 96-well plates and allowed to rest overnight after which medium was replaced with fresh Table 1 qPCR primers designed to quantify mRNA levels of mouse genes involved in microglial functions.
Gene Primer sequence
Tumor necrosis factor-α (TNFα) medium containing 1.0 μm fluorescent carboxylate-modified polystyrene latex beads (Sigma, L4655) at a concentration of 3.1×10 6 beads/well (50 beads/microglia). Microglia were incubated with the beads at 37°C for 2 h, then washed 3 times with ice-cold PBS. Microglia were examined using a Leica DM IRE2 fluorescence microscope (Leica Microsystems, Bannockburn, IL). The excitation wavelength for the beads was 505 nm. Phase and fluorescent images were captured using Open Lab 3.1.4 Software (PerkinElmer, Waltham, MA) and the number of beads associated with the microglia was quantified. As a control for beads that had bound to microglia without being internalized, parallel experiments were performed at 4°C to block phagocytosis. The number of beads associated with microglia at 4°C was subtracted from the number of beads associated with microglia at 37°C.
Statistical analysis
The statistical significance of differences was determined using the Student's t test. Differences were considered significant for P b 0.05.
Results
Microglia with an active morphology accumulate in Npc1
−/− mouse brains
Since microglia have been implicated in several neurodegenerative disorders, including NPC disease, we investigated the involvement of microglia in neuronal death in NPC disease. We first performed immunohistochemical analysis of brain slices from the cerebellum and cerebral cortex of Npc1 +/+ and Npc1 −/− mice. Sections were taken from 7-week-old mice and immunostained for the microglial marker Iba1. Mice of this age were selected since overt signs of NPC neurological disease are apparent in 7-week-old mice. In the Npc1 +/+ cerebellum (Fig. 1A) and cortex (Fig. 1C ) microglia were primarily detected in a ramified, resting morphology. In the Npc1 −/− cerebellum (Fig. 1B) and cortex ( Fig. 1D) , however, the number of microglia was markedly increased, and the Npc1 −/− microglia had swollen cell bodies and shortened processes, indicating that the microglia were activated. Thus, NPC1 deficiency in the brain markedly increases the number of microglia, and the morphology of the microglia shifts to a more activated phenotype.
Intracellular cholesterol distribution is altered in Npc1
The compound U18666A induces cholesterol sequestration in LE/Ls of cells, similar to the cholesterol trafficking defect in NPC1-deficient cells [41] . In preliminary experiments we incubated primary cultures of Npc1 +/+ microglia with U18666A (3 μM) for 6 h and examined the intracellular distribution of unesterified cholesterol by filipin staining. As expected, U18666A induced a bright punctate staining pattern in Npc1 +/+ microglia upon filipin staining (data not shown). This intracellular sequestration of cholesterol is typical of that exhibited by NPC-deficient cells such as fibroblasts [3] , sympathetic neurons [4] and astrocytes [5] . We next used filipin staining to compare the distribution of cholesterol in primary microglia isolated from Npc1 +/+ and Npc1 −/− mice. The Npc1 +/+ microglia showed a faint, diffuse intracellular filipin staining for cholesterol ( Fig. 2A ) that is likely attributable to cholesterol in the endosomal recycling compartment, a region of the cell that is enriched in cholesterol [42] . In contrast, Npc1 −/− microglia showed markedly increased intracellular filipin staining in a punctate pattern characteristic of that of other NPC-deficient cells in which cholesterol becomes sequestered in the LE/L [3, 4] (Fig. 2B ). These data show that NPC1 deficiency in the microglia causes the intracellular sequestration of cholesterol. and Npc1 −/− (panel B) mice. The microglia were allowed to rest overnight then stained with filipin for detection of unesterified cholesterol. Shown are representative images from 3 independent microglial preparations.
Pro-and anti-inflammatory cytokines and oxidative stress genes in NPC1-deficient microglia
Microglia produce pro-and anti-inflammatory cytokines as well as molecules involved in oxidative stress and cell proliferation. To determine if NPC1 deficiency altered the expression of these factors, we quantified levels of mRNAs encoding some of these proteins in primary microglia isolated from Npc1 −/− and Npc1 +/+ mice. The amounts of mRNAs encoding the pro-inflammatory cytokines TNFα and interleukin-1β (IL1β) were not significantly different between Npc1
−/− and Npc1 +/+ microglia (Fig. 3A) . Nor did NPC1 deficiency increase the amount of TNFα secreted into the medium by microglia during a 24 h period (Fig. 4) . Moreover, levels of mRNAs encoding markers of oxidative stress, such as inducible nitric oxide synthase (iNOS, which produces nitric oxide [43] ), and NADPH oxidase (NADPHox, which produces superoxide [44] , were similar in Npc1 −/− and Npc1 +/+ microglia (Fig. 3B) . Thus, NPC1 deficiency does not appear to increase the expression of genes involved in the generation of reactive oxygen species in microglia. However, the amount of mRNA encoding the anti-inflammatory cytokine interleukin-10 (IL10) was~60% lower in Npc1 −/− microglia than in Npc1 +/+ microglia (Fig. 3C ), although the level of mRNA encoding another anti-inflammatory cytokine, transforming growth factor-β (TGFβ), was not different between Npc1 −/− and Npc1 +/+ microglia (Fig. 3C) . Additionally, we quantified the mRNAs encoding glutaminase (which produces glutamate that can lead to excitotoxic death [45] ) and the macrophage colonystimulating factor receptor (which is involved in microglial proliferation and activation [46] ). No significant differences in expression of these genes were observed between Npc1 −/− and Npc1 +/+ microglia (Fig. 3D) . These results indicate that although NPC1 deficiency in the CNS induces an activated morphology in microglia, the production of pro-inflammatory cytokines and markers of oxidative stress was not increased in primary cultures of Npc1
microglia. On the other hand, since the level of IL10 mRNA was lower in Npc1 −/− microglia than in Npc1 +/+ microglia, specific protective functions, or the suppression of an inflammatory response, might be impaired in Npc1 −/− microglia.
Neuronal apoptosis is not increased by NPC1 deficiency in microglianeuron co-cultures
Since NPC disease is characterized by extensive neurodegeneration, we determined whether or not NPC1 deficiency in isolated neurons compromised neuronal survival. We cultured cerebellar granule cells (CGCs) from Npc1 +/+ and Npc1 −/− mice for 7 days, then quantified the extent of neuronal death by staining the cells with Hoechst stain to detect condensed nuclei that are typical markers of apoptotic cell death [47] . The percentage of apoptotic neurons in the CGC cultures was~20% and was independent of Npc1 genotype (Fig. 5) We also established co-cultures of neurons (CGCs) with microglia. The microglia were plated at either a low density (25% of the number of neurons) or a high density (50% of the number of neurons), directly on top of the CGC cultures. Different combinations of Npc1 genotypes of neurons and microglia were plated together so that co-cultures of Npc1 +/+ or Npc1 −/− CGCs were established with either Npc1 +/+ or Npc1 −/− microglia. After 24 h, the cells were fixed and stained for specific neuronal (MAP2) and microglial (Iba1) marker proteins. The percentage of Npc1 −/− neurons that were apoptotic, according to Hoechst staining, was similar (20-23%) when the neurons were cocultured with a low density of either Npc1 +/+ or Npc1 −/− microglia (Fig. 6A) . In addition, when Npc1 +/+ CGCs were cultured with a low density of microglia the extent of neuronal death (18-22%) was independent of Npc1 genotype of the microglia (Fig. 6A) . Similarly, when Npc1 −/− neurons were cultured with a high concentration of microglia, the number of neurons that were apoptotic (12-17%) was independent of the Npc1 genotype of the microglia (Fig. 6B) . On the other hand, the number of apoptotic Npc1 +/+ neurons was significantly lower when the neurons were cultured in the presence of a high concentration of Npc1 The conditions we used for culture of neurons were selected for maximal survival. We, therefore, considered the possibility that the optimal amounts of growth factors present in the neuronal culture medium had prevented factors secreted by the microglia from inducing neuronal apoptosis. Consequently, we performed experiments with microglia and cortical neurons co-cultured in the presence of Neurobasal A medium lacking any growth supplements. Under these conditions, neuronal apoptosis was~50% after 48 h and was independent of Npc1 genotype of both neurons and microglia.
We conclude that the survival of CGCs and cortical neurons cultured in vitro does not appear to be inherently reduced by NPC1 deficiency. Moreover, Npc1 −/− microglia do not compromise neuronal survival when these microglia are co-cultured with either Npc1 −/− or Npc1 +/+ neurons.
Phagocytosis is not impaired in Npc1
−/− microglia Microglia are phagocytic cells of the CNS that engulf degenerating cells and other debris [19] . Therefore, to determine if the sequestration of cholesterol within Npc1 −/− microglia altered their phagocytic capability, microglia were incubated for 2 h with fluorescent latex beads, then extensively washed and the number of beads that were internalized by the microglia was quantified. As a control for beads that had attached to the cells, but had not been internalized, parallel cultures were incubated at 4°C in order to block phagocytosis. The number of cell-associated beads at 4°C was subtracted from the number of beads associated with the cells at 37°C. Fig. 7 shows that the number of latex beads phagocytosed by Npc1 −/− microglia and Npc1 +/+ microglia was not significantly different. Thus, according to this criterion of microglial activity, phagocytosis by microglia is not impaired by NPC1 deficiency.
Discussion
Accumulation of active microglia in NPC1-deficient brains
Inappropriate activation of microglia has been implicated in several neurodegenerative disorders including NPC disease [13, 33, 34] . Consistent with the findings of others [13, 48] , we observed a marked accumulation of microglia with activated morphology in Npc1 −/− mouse brains. As in other NPC1-deficient cells, filipin staining revealed a pronounced intracellular sequestration of unesterified cholesterol in Npc1 −/− microglia. However, the levels of mRNAs encoding proinflammatory cytokines and oxidative stress proteins were not increased by NPC1 deficiency in primary cultures of microglia. These data suggest that the microglia that accumulate in NPC1-deficient mouse brains are not activated solely by NPC1 deficiency in the microglia, but by an additional insult, such as neuron death. Evidence is accumulating that macrophages can cross the blood-brain barrier from the circulation, particularly in states of disease and inflammation [49, 50] . Thus, the proliferation of Iba1-positive cells in NPC1-deficient mouse brains might also be due, at least in part, to an infiltration of macrophages since Iba1 is expressed in both microglia and macrophages [51, 52] .
Consequences of NPC1 deficiency on cytokine production by microglia
Microglia are the major source of TNFα in the CNS [53] and TNFα is often associated with inflammation-mediated cell death. Since increased levels of mRNAs encoding TNFα (and other genes involved in the TNFα death pathway) have been detected in brains [9] and livers [54, 55] [56] . Furthermore, the highest concentration of activated microglia in Npc1 −/− mouse brains was detected in areas of the brain in which neurodegeneration was most pronounced [56] . Ultimately, the role of microglia is to maintain brain health. Although microglia are capable of exerting cytotoxic effects, microglia can also be neuroprotective [25] [26] [27] . For example, microglia secrete IL10, an antiinflammatory cytokine that decreases the synthesis of pro-inflammatory cytokines, such as TNFα and interleukin-1β, as well as reactive oxygen species, both in vitro and in vivo [57] [58] [59] [60] . Following lipopolysaccharideinduced inflammation in the rat cerebral cortex, IL10 immunostaining was primarily detected in activated microglia [61] . When IL10 activity was abrogated with anti-IL10 antibodies, neuronal death increased, as did the amounts of reactive oxygen species and pro-inflammatory cytokines [61] . IL10 can also prevent excitotoxic death of neurons, apparently via inhibition of pro-apoptotic proteins such as caspase-3 [62, 63] . Our studies revealed that NPC1 deficiency in primary cultures of microglia significantly reduced the level of the mRNA encoding IL10. It is possible that the decrease in the amount of IL10 mRNA that we observed in Npc1 −/− microglia attenuates the ability of the microglia to prevent neuronal death. Thus, the reduction in IL10 production might lead to chronic activation of Npc1 −/− microglia and the prolonged production of pro-inflammatory cytokines and other neurotoxic molecules that would eventually contribute to neuron death in the CNS.
Microglia-neuron co-cultures
Active microglia have been detected in NPC1-deficient mouse brains prior to any detectable neurodegeneration [13] , suggesting that NPC1-deficient microglia might initiate neuron death in NPC disease. Our experiments with microglia-neuron co-cultures demonstrate that the survival of CGCs is not compromised when the neurons are cultured in the presence of Npc1 , microglia. This observation is consistent with the idea that NPC1 deficiency in microglia does not initiate neuron death. Interestingly, in the presence of high concentrations of microglia, less neuronal apoptosis occurred when Npc1 −/− neurons were cultured with Npc1 −/− microglia, than when Npc1 +/+ neurons were cultured with Npc1 +/+ microglia. Whether or not this neuroprotective effect would be physiologically relevant is not clear since the number of apoptotic neurons was only 10-20% under all culture conditions. Thus, our results support in vivo studies in which Purkinje cell death in NPC disease was shown to be cell autonomous [48, 56, 64] . For example, NPC1 deficiency in Purkinje cells alone caused Purkinje cell death despite other cells of the brain, including microglia, Fig. 7 . Phagocytosis of latex beads is not impaired in Npc1 −/− microglia. Microglia were isolated from Npc1 +/+ (black bar) or Npc1 −/− (white bar) mice and allowed to rest overnight. Carboxylate-modified poylstyrene latex beads were added to the culture medium and incubated with the microglia for 2 h at 37°C. The cells were extensively washed and the number of beads per microglial cell was quantified. As a control for binding of beads in the absence of uptake, microglia were incubated with beads for 2 h at 4°C, and these values were subtracted from the total number of beads associated with the microglia at 37°C. Values are means ± S.E. from N 600 microglia in 3 independent experiments. P N 0.05 (Student's t test).
having the Npc1 +/+ genotype. Furthermore, when NPC1 was inducibly expressed specifically in neurons in different regions of the brain of Npc1 −/− mice, such as the thalamus, cholesterol accumulation in the neurons was eliminated, neurodegeneration was prevented, and glial activity was reduced [56] . Our results expand on these findings by showing that in microglia-neuron co-cultures, NPC1 deficiency in microglia does not cause neuronal death. Nevertheless, it is important to note that our findings do not preclude the involvement of microglia in NPC disease progression since extensive interactions occur among the different cell types within the intact brain. Thus, although NPC1 deficiency in neurons appears to be the primary cause of neuronal death in NPC-deficient brains, chronic microglial activation and inflammation in the CNS might occur in response to neuron death which might exacerbate the neurodegeneration. Indeed, anti-inflammatory therapy delayed the onset of neurological symptoms and prolonged the lifespan of Npc1 −/− mice [65] . Thus, our data support the view that the loss of NPC1 in microglia is not the primary cause of CNS pathogenesis in NPC disease.
Conclusions
We show that Npc1 −/− microglia sequester cholesterol intracellularly. Although microglia with an activated morphology proliferate in NPC1-deficient mouse brains, NPC1 deficiency in primary cultures of microglia does not increase the secretion of the pro-inflammatory cytokine, TNFα, or the level of mRNAs encoding oxidative stress genes in microglia. On the other hand, the level of mRNA encoding IL10, an antiinflammatory cytokine, was lower in Npc1 −/− microglia than in Npc1 +/+ microglia. Our data also show that the survival of primary cultures of neurons was not impaired by NPC1 deficiency. Furthermore, Npc1
−/− microglia did not induce neuron death in microglia-neuron co-cultures. Thus, while Npc1 −/− microglia might exacerbate the neurodegeneration in Npc1 −/− brains, NPC1 deficiency in microglia alone appears to be insufficient to initiate neuron death.
